Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

Background: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and the UK confirm the vulnerability of HM patients to s...

Full description

Bibliographic Details
Main Authors: Lenin Mahimainathan, Madhusudhanan Narasimhan, Rolando Corchado, Hetalkumari Patel, Ankit Kansagra, Sridevi Devaraj, Praveen Ramakrishnan Geethakumari, Alagarraju Muthukumar
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Diagnostics
Subjects:
COVID-19
SARS-CoV-2
therapeutic monoclonal antibodies
serology
cross-reactivity
M-spike
Online Access:https://www.mdpi.com/2075-4418/10/12/992

Internet

https://www.mdpi.com/2075-4418/10/12/992

Similar Items